Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Laparoscopic liver surgery generally offers a faster recovery and fewer complications than open surgery, which can improve quality of life, though long-term survival is similar.
Yes, new combination strategies for liver cancer are emerging, including immunotherapy with anti-angiogenic drugs, and surgical techniques like hepatic vein occlusion with portal…
Yes, pregabalin at 300 or 600 mg/day significantly reduces pain in painful diabetic peripheral neuropathy, though duloxetine may be slightly more effective and gabapentin less so.
A loss of protective sensation in the feet is linked to more severe clinical complications, such as ulcers and amputations, in patients with diabetic peripheral neuropathy.
Nerve decompressive surgery can reduce pain in diabetic peripheral neuropathy, but evidence is mixed and limited by study quality; discuss risks and benefits with your doctor.
People with SDHD mutations are frequently associated with multifocal tumors, which can include multiple pheochromocytoma or paraganglioma sites.
Deep learning and radiomics are promising tools that can help doctors distinguish pheochromocytoma from other types of adrenal masses using medical imaging.
Contrast-enhanced mammography (CEM) has high sensitivity for detecting malignancy, but its specificity is reported at approximately 80% in some studies.
Women with malignancies can preserve fertility through validated methods like oocyte and embryo cryopreservation, as well as experimental options like ovarian tissue freezing.
Yes, DNA methylation testing is highly accurate for identifying CIN2+ and CIN3+, with several markers showing sensitivity over 89% and specificity over 95% in recent studies.
Cumulative gamification delivery significantly increases daily step counts in young adults compared to other methods.
Gamification techniques like points and leaderboards can significantly increase daily step counts in young adults to combat physical inactivity.
Mental contrasting techniques combined with implementation intentions have been shown to increase physical activity levels among employees in a workplace setting.
GLP-1 receptor agonists reduce major adverse limb events (MALE) and cardiovascular risks in people with type 2 diabetes and peripheral artery disease, based on meta-analyses.
Yes, tirzepatide may reduce major adverse limb events and cardiovascular risks in people with PAD, but direct trial data are still limited.
Yes, GLP-1 receptor agonists (liraglutide, semaglutide) improve walking distance in people with type 2 diabetes and peripheral artery disease, based on a 2025 meta-analysis of…
Incretin analogues (GLP-1 RAs) reduce cardiovascular risk in PAD by improving walking distance, lowering inflammation, and decreasing heart attack and stroke events.
Yes, GLP-1 receptor agonists reduce major limb events in patients with type 2 diabetes and peripheral artery disease, with a 27% lower risk shown in a 2026 meta-analysis.
Aging causes intervertebral disc degeneration through cellular senescence, loss of developmental signals, and metabolic changes that lead to tissue breakdown.
Epigenetic remodeling is an emerging research area aimed at reversing cellular aging and repairing tissue damage in intervertebral disc degeneration.
Yes, hemithyroidectomy is associated with a higher recurrence rate for differentiated thyroid cancer, with a 3% absolute risk increase compared to total thyroidectomy.
Senolytic clearance is an emerging research strategy to treat intervertebral disc degeneration by removing senescent cells that contribute to tissue breakdown.
Yes, emerging evidence suggests intervertebral disc degeneration can lead to spinal cord injury through a cascade involving ferroptosis, iron deposition, and increased…
Targeting metabolic checkpoints is an emerging research strategy to address the underlying biological causes of intervertebral disc degeneration rather than just treating symptoms.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.